Christina M. McKinney, MD; Michelle L. Mitchell, MD; Erin Preloger, MD; Kelly Graff, MD; Amy Y. Pan, PhD; Melodee Liegl, MA; Glenn Bushee, MS; Patrick J. McCarthy, MD, MME; Vanessa McFadden, MD, PhD; Sarah Corey Bauer, MD
WMJ. 2026;125(2):280-282. Published June 2, 2026.
ABSTRACT
Background: Expected ranges for several inflammatory markers in children were poorly defined during the COVID-19 pandemic, making it difficult to distinguish common infections from multisystem inflammatory syndrome in children (MIS-C). We evaluated less commonly obtained inflammatory markers in children with common bacterial infections.
Methods: We completed a retrospective cohort study at a tertiary children’s hospital from March 2018 through April 2023 of hospitalized patients >60 days to 21 years with cellulitis, community-acquired pneumonia, or urinary tract infection.
Results: A total of 973 patients were included (median age, 5.6 years; interquartile range, 1.9-12.2; 61% female). Most inflammatory markers were elevated across infections, whereas troponin levels remained within the reference range for all diagnoses.
Discussion: We report values for less commonly obtained inflammatory markers in children hospitalized with common bacterial infections. Normal troponin levels may help distinguish these infections from MIS-C, which more commonly involves cardiac inflammation. Further research is needed to define clinically useful cutoff values for inflammatory markers to aid decision-making in the setting of emerging disease processes.